lobbying_activities: 1519305

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1519305	d8433718-f870-492c-8488-2f9f95fee107	Q1	BROWN RUDNICK LLP	287895	HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC	2014	first_quarter	PHA	H.R. 4069-Ensuring Patient Access and Effective Drug Enforcement Act"; Rescheduling of Hydrocodone Combination Products From Schedule III to Schedule II [NPRM Docket No. DEA-389]	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2014-04-16T14:47:57.333000-04:00